VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 72 filers reported holding VERASTEM INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13,350 | +1.0% | 32,153 | -2.1% | 0.00% | 0.0% |
Q4 2022 | $13,223 | -57.3% | 32,853 | -11.3% | 0.00% | -50.0% |
Q3 2022 | $31,000 | -27.9% | 37,040 | 0.0% | 0.00% | -33.3% |
Q2 2022 | $43,000 | -18.9% | 37,040 | -1.0% | 0.00% | 0.0% |
Q1 2022 | $53,000 | -33.8% | 37,400 | -3.7% | 0.00% | -25.0% |
Q4 2021 | $80,000 | -89.7% | 38,820 | -84.6% | 0.00% | -80.0% |
Q3 2021 | $778,000 | +48.8% | 252,800 | +96.7% | 0.02% | -25.9% |
Q2 2021 | $523,000 | +63.9% | 128,500 | -0.6% | 0.03% | +50.0% |
Q1 2021 | $319,000 | +15.6% | 129,300 | -0.1% | 0.02% | +12.5% |
Q4 2020 | $276,000 | +69.3% | 129,400 | -3.7% | 0.02% | +45.5% |
Q3 2020 | $163,000 | -30.9% | 134,430 | -1.9% | 0.01% | -35.3% |
Q2 2020 | $236,000 | -35.0% | 137,030 | -0.3% | 0.02% | -46.9% |
Q1 2020 | $363,000 | +79.7% | 137,470 | -8.6% | 0.03% | +128.6% |
Q4 2019 | $202,000 | -24.3% | 150,410 | -31.8% | 0.01% | -30.0% |
Q3 2019 | $267,000 | -21.5% | 220,498 | -2.0% | 0.02% | -23.1% |
Q2 2019 | $340,000 | -49.6% | 224,978 | -1.3% | 0.03% | -52.7% |
Q1 2019 | $675,000 | -23.6% | 227,898 | -13.3% | 0.06% | -33.7% |
Q4 2018 | $883,000 | -54.4% | 262,828 | -1.7% | 0.08% | -43.5% |
Q3 2018 | $1,938,000 | +5.3% | 267,328 | -0.1% | 0.15% | 0.0% |
Q2 2018 | $1,841,000 | +130.7% | 267,593 | -0.1% | 0.15% | +129.7% |
Q1 2018 | $798,000 | -3.7% | 267,903 | -0.8% | 0.06% | -3.0% |
Q4 2017 | $829,000 | -38.7% | 269,938 | -6.2% | 0.07% | -41.1% |
Q3 2017 | $1,353,000 | +111.1% | 287,815 | -2.1% | 0.11% | +107.4% |
Q2 2017 | $641,000 | +22.8% | 294,007 | +16.5% | 0.05% | +20.0% |
Q1 2017 | $522,000 | +83.8% | 252,391 | -0.4% | 0.04% | +73.1% |
Q4 2016 | $284,000 | -19.1% | 253,346 | -3.9% | 0.03% | -21.2% |
Q3 2016 | $351,000 | +1.7% | 263,659 | -0.5% | 0.03% | 0.0% |
Q2 2016 | $345,000 | -18.4% | 265,010 | -0.9% | 0.03% | -23.3% |
Q1 2016 | $423,000 | -16.1% | 267,455 | -1.2% | 0.04% | -15.7% |
Q4 2015 | $504,000 | -13.3% | 270,739 | -16.6% | 0.05% | -19.0% |
Q3 2015 | $581,000 | -76.4% | 324,618 | -0.8% | 0.06% | -75.1% |
Q2 2015 | $2,467,000 | -23.9% | 327,159 | +2.7% | 0.25% | -23.3% |
Q1 2015 | $3,241,000 | +22.4% | 318,654 | +10.0% | 0.33% | +25.0% |
Q4 2014 | $2,648,000 | +7.7% | 289,741 | +0.4% | 0.26% | +4.3% |
Q3 2014 | $2,459,000 | +1.6% | 288,671 | +8.1% | 0.25% | +2.4% |
Q2 2014 | $2,420,000 | -1.3% | 267,141 | +17.6% | 0.25% | -11.2% |
Q1 2014 | $2,451,000 | +240.4% | 227,165 | +259.6% | 0.28% | +212.4% |
Q4 2013 | $720,000 | +41.5% | 63,170 | +54.4% | 0.09% | +29.0% |
Q3 2013 | $509,000 | -9.3% | 40,920 | +1.3% | 0.07% | -22.5% |
Q2 2013 | $561,000 | – | 40,400 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,018,433 | $6,217,000 | 2.19% |
Altium Capital Management LP | 2,253,000 | $6,939,000 | 1.82% |
BVF INC/IL | 14,977,258 | $46,130,000 | 1.80% |
MPM BioImpact LLC | 2,824,857 | $8,701,000 | 1.35% |
Opaleye Management Inc. | 2,325,000 | $7,161,000 | 1.34% |
Tibra Equities Europe Ltd | 73,700 | $227,000 | 0.35% |
Baker Brothers Advisors | 21,491,630 | $66,194,000 | 0.29% |
Telemetry Investments, L.L.C. | 65,000 | $200,000 | 0.27% |
Ikarian Capital, LLC | 1,227,371 | $3,780,000 | 0.27% |
Parkman Healthcare Partners LLC | 175,797 | $541,000 | 0.14% |